Ainda não temos significados para "hematologic toxicity".
1Conclusions: Traditional CHM does not reduce the hematologic toxicity associated with chemotherapy.
2Neurotoxicity and hematologic toxicity were more severe on the higher dose arms.
3Of note, little severe hematologic toxicity and no significant headaches were reported.
4The remaining trials reported on hematologic toxicity in 16 different ways.
5Clinically significant myelosuppression was not observed; hematologic toxicity was generally mild and reversible.
6Furthermore, hematologic toxicity was extremely mild and appeared not to be dose dependent.
7No dose reductions, delays, or discontinuations were required for hematologic toxicity.
8In all cases, hematologic toxicity was short term and reversible.
9Results: We identified five PCs associated with acute hematologic toxicity.
10Therapy was well tolerated with the expected reversible hematologic toxicity.
11CSFs can, however, reduce the hematologic toxicity of chemotherapy, which represents the most significant result.
12Toxic effects included moderate hematologic toxicity, nausea, and vomiting.
13All patients evaluable for hematologic toxicity developed grade 4 neutropenia and thrombocytopenia during protocol therapy.
14Although manageable in an oncology setting, the hematologic toxicity of such a regimen remains substantial.
15Significant hematologic toxicity was observed and was not obviously related to the dose of trimetrexate.
16Major toxicities included hematologic toxicity, mucositis and infectious complications.
Esta colocação é formada por:
Hematologic toxicity ao longo do tempo
Hematologic toxicity nas variantes da língua
Estados Unidos da América